However, based on our aforementioned analysis, both TCGA database and clinical samples suggest that the low expression of FDX1 in COAD tissues may promote tumor progression by attenuating the cuproptosis effect induced by ES. This evidence concerns the gene FDX1 and colon adenocarcinoma.